The OTC-Hope Study, building hope one gene at a time logo.

COMING SOON!

OTC-HOPE study – a first-in-human study of a gene editing therapy for baby boys less than seven months of age with ornithine transcarbamylase (OTC) deficiency.

Baby boy that is resting his face on his folded hands, laying on a white blanket.

For additional information on this and other OTC deficiency clinical research studies, please visit ClinicalTrials.gov. If you are a healthcare provider and would like to learn more about this study, please email medinfo@iecure.com.

More information on this study will be coming. Check back soon.

CONTACT US

Please use this form to contact us if you would like to receive updates on the OTC-HOPE study.*

Baby boy's tiny four fingers wrapped around an adult index finger.